All companies
Zoetis logo
HealthcareZTS

Zoetis (ZTS) Financial Forecast Calculator

Interactive 5-year forecast and DCF for Zoetis. Adjust revenue growth, gross margin, capex intensity, WACC, and terminal growth - see revenue, free cash flow, and enterprise value update in real time. Seeded from Zoetis’s most recent SEC filings.

Revenue FY30
$12.60B
from $8.54B
FCF FY30
$3.92B
Margin 31.1%
Enterprise value
$55.18B
6.5× LTM revenue
Equity value
$52.19B
Net debt $2.99B
Revenue & free cash flow - history and 5-year forecast
Line (area)
Bars
Historicals from SEC EDGAR (grey). Forecast years (color) update live as you move the sliders.

Assumptions

Revenue growth (annual)
8.1%
-10.0%baseline 8.1%40.0%
Gross margin
69.5%
5.0%baseline 69.5%90.0%
Capex % of revenue
7.2%
0.0%baseline 7.2%30.0%
WACC (discount rate)
9.00%
4.0%baseline 9.0%18.0%
Terminal growth
2.50%
0.0%baseline 2.5%5.0%

Need this as an Excel model?

Keep iterating on the Zoetis forecast in Excel. The downloadable sample has every assumption you see here plus a fully integrated income statement, balance sheet, cash flow, and debt schedule - five years of SEC historicals and live formulas in a fully editable workbook.

income_statement.xlsx
Income statement, brown brand palette
income_statement.xlsx
Income statement, green brand palette
income_statement.xlsx
Income statement, red brand palette

Frequently asked

What does Zoetis do as an animal health company?+

Zoetis is the world's largest animal health company, focused on discovering, developing, manufacturing, and commercializing medicines, vaccines, and diagnostic products. It serves veterinarians, livestock producers, and pet owners across over 100 countries with a business model similar to human pharmaceuticals.

What are the primary revenue drivers for Zoetis?+

Zoetis generates revenue primarily from its United States and International segments, with the U.S. contributing approximately 54% of total revenue. Within these regions, Companion Animal products account for roughly 68% of total revenue, while Livestock products contribute about 31%.

What is the assumed revenue growth rate in the Zoetis financial model?+

The financial model for Zoetis assumes a revenue growth rate of approximately 8.1% for its forecast horizon. This growth, along with margin expansion and cash flow generation, is used to determine the company's equity valuation.

What is the main purpose of the Zoetis financial model?+

The primary purpose of the Zoetis financial model is to forecast the company's revenue growth, margin expansion, and cash flow generation. This analysis is crucial for determining its equity valuation and assessing the long-term earnings impact of its companion animal product pipeline.

Can I download an Excel financial model for Zoetis?+

Yes, an Excel financial model for Zoetis is available for download. This model provides forecasts for the company's performance from FY2026 through FY2030.

What are Zoetis's capital expenditure plans and assumptions?+

Zoetis's financial model assumes capital expenditure as approximately 7.2% of revenue, historically ranging from 5% to 7%. A significant portion, about 60%, is allocated to growth capex, specifically for expanding biological manufacturing capacity in the U.S. and Ireland to support key product rollouts.

Have more financial modelling questions? Contact us

Go further

Build the financial model you need with Fina

Browse templates, examples, and downloadable Excel models for the analysis you are trying to build. If you can't find your model, ask Fina to build a model for your specific needs.

Start for free
Excel financial model spreadsheet preview showing Customer Rollforward
Fina interactive chat interface preview